Evidence map›Paper›PMID 41278478›Full record

ReviewFrontiers in cellular and infection microbiology2025

Combating

Jiaxin Ding, Weilei Yan, Rui Zheng, Mengye Ma, Liming Jiang

Abstract readReview
In one paragraph

Review in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Biofilm-Mediated Antimicrobial Resistance in PediatricAntibiotics (Basel, Switzerland) · 2026
    Review
  2. Article
  3. TARGETING THE CAPSULE OFbioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. Article
  6. Phage therapy againstFrontiers in microbiology · 2026
    Review
  7. Antibiotic resistance inFrontiers in microbiology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jiaxin Ding *School of Basic Medical Sciences, Health Science Center, Ningbo University, Ningbo, China.
Weilei Yan *School of Basic Medical Sciences, Health Science Center, Ningbo University, Ningbo, China.
Rui Zheng *Department of Clinical Laboratory, The First People's Hospital of Yunnan Province, Kunming, China.
Mengye MaSchool of Basic Medical Sciences, Health Science Center, Ningbo University, Ningbo, China.
Liming JiangSchool of Basic Medical Sciences, Health Science Center, Ningbo University, Ningbo, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug Resistance, BacterialKlebsiella InfectionsKlebsiella pneumoniaePhage TherapyAnti-Bacterial AgentsBacteriophagesCombined Modality TherapyDrug Resistance, Multiple, BacterialHumansAnti-Bacterial Agentsantimicrobial resistance mechanismsclinical translationK.pneumoniaephagephage-based combination therapy

Identifiers

PMID41278478
PMCPMC12634562

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.